کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
1194006 1492282 2013 7 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Electrospray ionization tandem mass spectrometric studies of copper and iron complexes with tobramycin
موضوعات مرتبط
مهندسی و علوم پایه شیمی شیمی آنالیزی یا شیمی تجزیه
پیش نمایش صفحه اول مقاله
Electrospray ionization tandem mass spectrometric studies of copper and iron complexes with tobramycin
چکیده انگلیسی

Tobramycin is an aminoglycoside antibiotic that shows antimicrobial activity against a wide spectrum of aerobic bacteria. This paper describes the electrospray ionization mass spectrometric analysis of metallo (Cu(II) and Fe(III))–tobramycin complexes. The Cu(II) (1.5 × 10−4 M) and Fe(III) (1.5 × 10−4 M) ions co-ordinate with tobramycin (1.5 × 10−4 M) at 1:1 molar ratio for 30 min at room temperature. ESI mass spectrum of tobramycin shows ions at m/z 468.1, 934.8, and 234.8 corresponding to mono-protonated ([M+H]+), dimer ([2M+H]+) and di-protonated ([M+2H]2+), respectively. The Cu(II) and Fe(III) complexes show preferentially different molar ratio as 1:1, 1:2 and 1:3 such as [63Cu+(M−2H)+H]+, [65Cu + (M−2H) + H]+, [63Cu + (M−2H) + 2H2O + H]+, [65Cu + (M−2H) + 2H2O + H]+, [Fe + (M−3H) + 2H2O + H]+, [Fe + (2M−3H) + 2H2O + H]+, [Fe + (M−3H) + H2O + H]+ and [Fe + (M−3H) + H]+, respectively. Therefore, ESI-MS provides a simple, accurate and reproducible method for the identification of Cu(II)– and Fe(III)–tobramycin complexes ions than the other conventional methods (the method of continuous variations, the mole-ratio method, the slope-ratio method, computer-based curve-flitting methods).

Figure optionsDownload high-quality image (88 K)Download as PowerPoint slideHighlights
► Probe the noncovalent interaction between metals and tobramycin.
► Interpretation the ESI-MS peaks of the metallodrug complexes.
► Check the tandem mass of each metallodrug.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: International Journal of Mass Spectrometry - Volume 338, 15 March 2013, Pages 23–29
نویسندگان
, , , , ,